Multi-country

Lifelong exercise protects the heart. It can also make the heart harder to read

If BMI misses cardiovascular risk, why is policy still built around it?

AstraZeneca’s potential $1.5B insitro deal puts AI on the hardest question in cardiometabolic R&D

Ten Years of MS Data Make Delay Harder to Defend

Europe is building the infrastructure to decide which cardiovascular AI can be trusted

Preparedness Finally Has Capital

Tirzepatide’s Next Question: What Lies Beyond Cardiovascular Events?

Precision Oncology Has a Scale Problem

The gut microbiome is entering rehabilitation medicine. The evidence is not ready for routine care
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
